424 related articles for article (PubMed ID: 28052030)
41. The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121.
Peng Y; Zhou Y; Cheng L; Hu D; Zhou X; Wang Z; Xie C; Zhou F
Biochem Biophys Res Commun; 2015 Sep; 465(1):137-44. PubMed ID: 26235881
[TBL] [Abstract][Full Text] [Related]
42. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?
Benson SC; Iguchi R; Ho CI; Yamamoto K; Kurtz TW
J Hypertens; 2008 May; 26(5):973-80. PubMed ID: 18398340
[TBL] [Abstract][Full Text] [Related]
44. Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab.
Yamazaki M; Yamashita Y; Kubo N; Yashiro M; Ohira M; Ako E; Tanaka H; Muguruma K; Sawada T; Hirakawa K
Oncol Rep; 2012 Jul; 28(1):49-54. PubMed ID: 22562413
[TBL] [Abstract][Full Text] [Related]
45. Regulation of ERBB2 receptor by t-DARPP mediates trastuzumab resistance in human esophageal adenocarcinoma.
Hong J; Katsha A; Lu P; Shyr Y; Belkhiri A; El-Rifai W
Cancer Res; 2012 Sep; 72(17):4504-14. PubMed ID: 22745369
[TBL] [Abstract][Full Text] [Related]
46. The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin.
Kato K; Iwama H; Yamashita T; Kobayashi K; Fujihara S; Fujimori T; Kamada H; Kobara H; Masaki T
Oncol Rep; 2016 Mar; 35(3):1582-92. PubMed ID: 26708419
[TBL] [Abstract][Full Text] [Related]
47. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
[TBL] [Abstract][Full Text] [Related]
48. Wogonoside induces apoptosis in human non-small cell lung cancer A549 cells by promoting mitochondria dysfunction.
Luo M; Mo J; Yu Q; Zhou S; Ning R; Zhang Y; Su C; Wang H; Cui J
Biomed Pharmacother; 2018 Oct; 106():593-598. PubMed ID: 29990847
[TBL] [Abstract][Full Text] [Related]
49. Isogambogenic Acid Inhibits the Growth of Glioma Through Activation of the AMPK-mTOR Pathway.
Zhao W; Peng F; Shu M; Liu H; Hou X; Wang X; Ye J; Zhao B; Wang K; Zhong C; Xue L; Gao M; Liu Y; Zhao S
Cell Physiol Biochem; 2017; 44(4):1381-1395. PubMed ID: 29186708
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic potential of the antidiabetic drug metformin in small bowel adenocarcinoma.
Chiyo T; Kato K; Iwama H; Fujihara S; Fujita K; Tadokoro T; Ohura K; Samukawa E; Yamana Y; Kobayashi N; Matsunaga T; Nishiyama N; Ayaki M; Yachida T; Morishita A; Kobara H; Mori H; Masaki T
Int J Oncol; 2017 Jun; 50(6):2145-2153. PubMed ID: 28440424
[TBL] [Abstract][Full Text] [Related]
51. MK8722, an AMPK activator, inhibiting carcinoma proliferation, invasion and migration in human pancreatic cancer cells.
Wang C; Huang B; Sun L; Wang X; Zhou B; Tang H; Geng W
Biomed Pharmacother; 2021 Dec; 144():112325. PubMed ID: 34656065
[TBL] [Abstract][Full Text] [Related]
52. Antitumor effects of a novel benzonaphthofurandione derivative (8e) on the human colon cancer cells in vitro and in vivo through cell cycle arrest accompanied with the modulation of EGFR and mTOR signaling.
Chung HJ; Rhee HK; Lee SK; Park Choo HY
Chem Biol Interact; 2011 Aug; 193(1):43-9. PubMed ID: 21600193
[TBL] [Abstract][Full Text] [Related]
53. Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation.
Isobe A; Takeda T; Sakata M; Miyake A; Yamamoto T; Minekawa R; Nishimoto F; Oskamoto Y; Walker CL; Kimura T
Hum Reprod; 2008 Feb; 23(2):440-6. PubMed ID: 17993476
[TBL] [Abstract][Full Text] [Related]
54. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
55. β-Cryptoxanthin induced anti-proliferation and apoptosis by G0/G1 arrest and AMPK signal inactivation in gastric cancer.
Gao M; Dang F; Deng C
Eur J Pharmacol; 2019 Sep; 859():172528. PubMed ID: 31288004
[TBL] [Abstract][Full Text] [Related]
56. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
[TBL] [Abstract][Full Text] [Related]
57. The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region.
Jeon WK; Choi J; Park SJ; Jo EJ; Lee YK; Lim S; Kim JH; Letterio JJ; Liu F; Kim SJ; Kim BC
Oncotarget; 2015 Dec; 6(39):41650-66. PubMed ID: 26497676
[TBL] [Abstract][Full Text] [Related]
58. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
Kusunoki H; Taniyama Y; Azuma J; Iekushi K; Sanada F; Otsu R; Iwabayashi M; Okayama K; Rakugi H; Morishita R
Hypertension; 2012 Feb; 59(2):308-16. PubMed ID: 22252391
[TBL] [Abstract][Full Text] [Related]
59. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
60. Isoliquiritigenin Suppressed Esophageal Squamous Carcinoma Growth by Blocking EGFR Activation and Inducing Cell Cycle Arrest.
Ye L; Zhang J; Zhang Y; Gu B; Zhu H; Mao X
Biomed Res Int; 2020; 2020():9259852. PubMed ID: 32190688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
